Literature DB >> 29456073

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.

Adil Mardinoglu1, Hao Wu2, Elias Bjornson3, Cheng Zhang4, Antti Hakkarainen5, Sari M Räsänen6, Sunjae Lee4, Rosellina M Mancina2, Mattias Bergentall2, Kirsi H Pietiläinen7, Sanni Söderlund6, Niina Matikainen7, Marcus Ståhlman2, Per-Olof Bergh2, Martin Adiels2, Brian D Piening8, Marit Granér6, Nina Lundbom5, Kevin J Williams2, Stefano Romeo2, Jens Nielsen9, Michael Snyder8, Mathias Uhlén4, Göran Bergström2, Rosie Perkins2, Hanns-Ulrich Marschall2, Fredrik Bäckhed10, Marja-Riitta Taskinen6, Jan Borén11.   

Abstract

A carbohydrate-restricted diet is a widely recommended intervention for non-alcoholic fatty liver disease (NAFLD), but a systematic perspective on the multiple benefits of this diet is lacking. Here, we performed a short-term intervention with an isocaloric low-carbohydrate diet with increased protein content in obese subjects with NAFLD and characterized the resulting alterations in metabolism and the gut microbiota using a multi-omics approach. We observed rapid and dramatic reductions of liver fat and other cardiometabolic risk factors paralleled by (1) marked decreases in hepatic de novo lipogenesis; (2) large increases in serum β-hydroxybutyrate concentrations, reflecting increased mitochondrial β-oxidation; and (3) rapid increases in folate-producing Streptococcus and serum folate concentrations. Liver transcriptomic analysis on biopsy samples from a second cohort revealed downregulation of the fatty acid synthesis pathway and upregulation of folate-mediated one-carbon metabolism and fatty acid oxidation pathways. Our results highlight the potential of exploring diet-microbiota interactions for treating NAFLD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGF21; NAFLD; PPAR-α; Streptococcus; carbohydrate-restricted diet; folate; inflammation; microbiome; multi-omics; β-oxidation

Mesh:

Substances:

Year:  2018        PMID: 29456073      PMCID: PMC6706084          DOI: 10.1016/j.cmet.2018.01.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  114 in total

Review 1.  How diet and the microbiome shape health or contribute to disease: A mini-review of current models and clinical studies.

Authors:  Megan T Zangara; Christine McDonald
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-31

2.  An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment.

Authors:  Marialena Mouzaki; Rohit Loomba
Journal:  Curr Treat Options Gastroenterol       Date:  2020-05-02

Review 3.  Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota.

Authors:  Rachel M Golonka; Xia Xiao; Ahmed A Abokor; Bina Joe; Matam Vijay-Kumar
Journal:  J Nutr Biochem       Date:  2020-02-22       Impact factor: 6.048

4.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

5.  Influence of short-term changes in dietary sulfur on the relative abundances of intestinal sulfate-reducing bacteria.

Authors:  Allison Dostal Webster; Christopher Staley; Matthew J Hamilton; Merry Huang; Kathryn Fryxell; Raymond Erickson; Amanda J Kabage; Michael J Sadowsky; Alexander Khoruts
Journal:  Gut Microbes       Date:  2019-02-27

6.  Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis.

Authors:  Xiangbo Ruan; Ping Li; Yonghe Ma; Cheng-Fei Jiang; Yi Chen; Yu Shi; Nikhil Gupta; Fayaz Seifuddin; Mehdi Pirooznia; Yasuyuki Ohnishi; Nao Yoneda; Megumi Nishiwaki; Gabrijela Dumbovic; John L Rinn; Yuichiro Higuchi; Kenji Kawai; Hiroshi Suemizu; Haiming Cao
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 7.  Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease.

Authors:  Karoline Sandby; Nina Rica Wium Geiker; Maria Dalamaga; Henning Grønbæk; Faidon Magkos
Journal:  Curr Obes Rep       Date:  2021-02-13

Review 8.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

9.  Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial.

Authors:  Lingli Cai; Jun Yin; Xiaojing Ma; Yifei Mo; Cheng Li; Wei Lu; Yuqian Bao; Jian Zhou; Weiping Jia
Journal:  Front Med       Date:  2021-06-29       Impact factor: 4.592

Review 10.  Carbotoxicity-Noxious Effects of Carbohydrates.

Authors:  Guido Kroemer; Carlos López-Otín; Frank Madeo; Rafael de Cabo
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.